COMBINED B-GROUP VITAMINS FOR DIABETIC POLYNEUROPATHY
- Authors: Alekseev A.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 23, No 7 (2012)
- Pages: 59-62
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115467
- ID: 115467
Cite item
Open Access
Access granted
Abstract
The capacities of pathophysiological and symptomatic therapy for diabetic polyneuropathy with B complex vitamin preparations, including Neurobion, are discussed.
Full Text
About the authors
A. Alekseev
I.M. Sechenov First Moscow State Medical University
Email: alekseevalexeyv@mail.ru
References
- Балаболкин М.И., Креминская В.М., Диабетическая невропатия // Журн. неврол. и психиатр. - 2000; 10: 58-64.
- Young M., Boulton A., MacLeod A. et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population // Diabetologia, - 1993; 36: 1-5.
- Gorson K., Ropper A. Additional causes for distal sensory polyneuropathy in diabetic patients // J. Neurol. Neurosurg. Psychiatr. - 2006;77; 354-8.
- Benbow S., Wallymahmed M., MacFarime I. Diabetic peripheral neuropathy and quality of life // QJ Med. - 1998; 91: 733-7.
- Rashid G., Benchetrit S. et al. Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells. - 2004; 66 (3): 1099-106.
- Pomero F., Molinar M., La Selva M. et al. Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose // Acta Diabetol. -2001; 38: 135-8.
- Havivi E., Bar On, H., Reshef A. et al. Vitamins and trace metals status in non insulin dependent diabetes mellitus. Internat // J. Vit. Nutr. Res. -1991; 61: 328-33.
- Nishikawa T., Edelstein D., Liang Du X. et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemia damage // Nature. -2000; 404: 787-90.
- Woelk H. et al. Benfotiamine in the treatment of alcoholic polyneuropathy (BAP-I-Study). Alc. & Alcoholism. - 1998; 6 (33): 631-5.
- Beuker F., Bitsch R., Stemper Th. et al. Vitaminspur 11. -1996; 137-41.
- Reiners K., Haupt S. Vitaminspur 11. - 1996; 74-84.
- La Selva, M., Beltramo, E., Pagnozzi, F. et al. Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions // Diabetolog. - 1996; 39: 1263-8.
- IH I Tong. An. Acad. Med. - 1980; 9 (1).
- Lahoda E., Werner W. Einhorn-Presse Verlag, Reinbeck. - 1985: 57-64.
- Stracke H., Gaus W. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study // Exp. Clin. Endocrinol. Diabetes. - 2008; 116 (10): 600-5.
- Abbas Z., Swai A. Evaluation of the efficacy of thiamine and pyridoxine in the treatment of symptomatic diabetic peripheral neuropathy // East Afr. Med. -1997; 74 (12): 803-8.
- Simeonov S., Pavlova M., Mitkov M. et al. Therapeutic efficacy of «Milgamma» in patients with painful diabetic neuropathy // Folia Med. (Plovdiv) -1997; 39: 5-10.
- Stracke H., Lindemann A., Federlin K. A benfotiamine - vitamin B combination in treatment of diabetic polyneuropathy // Exp. Clin. Endocrinol. Diabetes. - 1996; 104: 311-6.
- Thornalley P., Babaei-Jadidi R., Al Ali H. et al. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease // Diabetol. - 2007; 50: 2164-70.
Supplementary files
